ARANESP
ARANESP
Approved
DIN Number
02391813
Drug Class
Human
Market Date
N/A
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02391813
AIG Number0148081008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B03XA02 DARBEPOETIN ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intravenous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DARBEPOETIN ALFAActive
Strength: 500 MCG / ML
Monograph: DARBEPOETIN ALFA